Cases Of Rare Lymphoma Linked To Breast Implants Increase

US FDA is now aware of 414 cases of breast implant-associated anaplastic large cell lymphoma. The agency says that updated medical literature estimates of the lifetime risk of textured breast implanted patients developing BIA-ALCL range between 1 in 3,817 to 1 in 30,000.

USFDA recorded 55 additional cases of a rare type of lymphoma linked to patients with textured breast implants in the last year, raising the total to 414 cases of BIA-ALCL reported via its Medical Device Reporting (MDR) adverse event system, including nine patient deaths. The March 21 updates on the link between both saline and silicone implants and the lymphoma can be viewed at FDA'sBIA-ALCLwebpage.

In March 2017, the agency reported it knew of 359 cases.

More from Regulation

More from Policy & Regulation